"The Big Horn Basin Cancer Center provides residents throughout Northern Wyoming access to some of the nations leading oncologists and cutting-edge technology right here at home. As the only facility in the region with both radiation and medical cancer treatments, we offer advanced treatment options and technology for all types of cancer. We are focused on you as a person, not just your diagnosis. We take the time to really get to know you and answer every one of your questions so we can provide the individualized care that fits your unique needs. Our patients are our neighbors, our friends, and our family."

During the past decade, Big Horn Basin Cancer Center conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 38 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 32 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Big Horn Basin Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "GOG Foundation" with 6 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Big Horn Basin Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Big Horn Basin Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Breast Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Big Horn Basin Cancer Center" in a lesser frequency.

Most popular intervention types in "Big Horn Basin Cancer Center" are "Drug" (58 trials), "Other" (50 trials), "Biological" (21 trials), "Procedure" (12 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (13 trials), "Cisplatin" (10 trials), "Docetaxel" (7 trials) and "Nivolumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Big Horn Basin Cancer Center" are 53 trials for "All" genders and 18 trials for "Female" genders.

Currently, there are NaN active trials in "Big Horn Basin Cancer Center". undefined are not yet recruiting, 7 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Big Horn Basin Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Big Horn Basin Cancer Center, 4 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".